Prostate cancer patients whose disease returns at the biochemical level after surgery may be able to undergo seven fewer ...

Dong-A ST has begun selling its anemia biosimilar Darbecron (DA-3880) in the United Arab Emirates (UAE), extending the ...

Celltrion's operating profit grew considerably faster than revenue in the third quarter, as newer, higher-margin biosimilars ...

A research team led by Professor Jung Se-young of the Department of Family Medicine at Seoul National University Bundang ...

Hanmi Pharmaceutical's first domestically developed GLP-1 obesity drug has won regulatory approval in Korea, setting up ...

With its second oligonucleotide manufacturing plant now in full operation, ST Pharm is using CPHI Worldwide 2026 in Milan, ...

Korean pharmaceutical and biotechnology companies will present cancer drug development data at ESMO Congress 2026 in Madrid ...

Despite major advances in psoriasis treatment, many Korean patients remain undertreated and face social stigma, prompting ...

Nearly three-quarters of foreign patient visits to medical departments in Korea last year were for dermatology or plastic ...

Korean biotech PRG S&Tech has begun enrolling patients in a U.S. phase 2 clinical trial of Progerinin, an experimental ...

A police raid on Ajou University Hospital’s pediatric emergency center drew scrutiny at a parliamentary audit Wednesday, ...

Korea's proposed 2027 budget allocates no funding to purchase tuberculosis (TB) drugs that the government has directly ...